Skip to main content
Erschienen in: Medical Oncology 7/2014

01.07.2014 | Original Paper

Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance

verfasst von: Xinxiu Lin, Man Yang, Tian Xia, Junming Guo

Erschienen in: Medical Oncology | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Long noncoding RNAs (lncRNAs) play an important role in basic physiological processes, also affect tumor occurrence and development. However, there are still many unknown relationships between the lncRNA expression levels and gastric tumor process. In our study, we selected ABHD11 Antisense RNA 1 (ABHD11-AS1) as a representative lncRNAs to study the different expression levels between gastric tumor and adjacent non-tumor tissues. At the same time, we analyzed the relationship between the expression levels of ABHD11-AS1 in gastric cancer tissues and the clinicopathological features of patients with gastric cancer and evaluated the diagnostic value through the receiver operation characteristic (ROC) curve. Results show that compared with adjacent non-tumor tissues the expression level of ABHD11-AS1 in gastric cancer tissues was significantly increased (P = 0.027). The expression level was also significantly related with the differentiation (P = 0.022), Lauren histologic classification (P = 0.004) and carbohydrate antigen 19-9 (CA19-9) (P = 0.007), and the area under ROC curve was up to 0.613. Thus, ABHD11-AS1 might be a potential biomarker for diagnosis of gastric cancer.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin Hai-Rim, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;217:2893–917. Ferlay J, Shin Hai-Rim, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;217:2893–917.
2.
Zurück zum Zitat Bu Z, Ji J. Therapeutic implications of mTOR inhibitors in the treatment of gastric cancer. Curr Cancer Drug Targets. 2013;13:121–5.PubMedCrossRef Bu Z, Ji J. Therapeutic implications of mTOR inhibitors in the treatment of gastric cancer. Curr Cancer Drug Targets. 2013;13:121–5.PubMedCrossRef
3.
Zurück zum Zitat Song H, Sun W, Ye G, et al. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med. 2013;11:225.PubMedCentralPubMedCrossRef Song H, Sun W, Ye G, et al. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med. 2013;11:225.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Crea F, Watahiki A, Quagliata L, et al. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget. 2014;5:764–74.PubMedCentralPubMed Crea F, Watahiki A, Quagliata L, et al. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget. 2014;5:764–74.PubMedCentralPubMed
6.
Zurück zum Zitat Ono H, Motoi N, Nagano H, Miyauchi E, Ushijima M, Matsuura M, et al. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer. Cancer Med. 2014;. doi:10.1002/cam4.220.PubMedCentral Ono H, Motoi N, Nagano H, Miyauchi E, Ushijima M, Matsuura M, et al. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer. Cancer Med. 2014;. doi:10.​1002/​cam4.​220.PubMedCentral
7.
Zurück zum Zitat Zhang J, Han L, Bao Z, et al. HOTAIR, a cell cycle—associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol. 2013;15:1595–603.PubMedCrossRef Zhang J, Han L, Bao Z, et al. HOTAIR, a cell cycle—associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol. 2013;15:1595–603.PubMedCrossRef
8.
Zurück zum Zitat Mei D, Song H, Wang K, et al. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med Oncol. 2013;30:709.PubMedCrossRef Mei D, Song H, Wang K, et al. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med Oncol. 2013;30:709.PubMedCrossRef
9.
Zurück zum Zitat Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2013;26:155–65.PubMedCrossRef Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2013;26:155–65.PubMedCrossRef
10.
Zurück zum Zitat Faghihi MA, Modarresi F, Khalil AM, et al. Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of β-secretase. Nat Med. 2008;14:723–30.PubMedCentralPubMedCrossRef Faghihi MA, Modarresi F, Khalil AM, et al. Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of β-secretase. Nat Med. 2008;14:723–30.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Lac atena RM, Cesareni G. Base pairing of RNA I with its complementary sequence in the primer precursor inhibits ColE1 replication. Nature. 1981;294:623–6. Lac atena RM, Cesareni G. Base pairing of RNA I with its complementary sequence in the primer precursor inhibits ColE1 replication. Nature. 1981;294:623–6.
12.
Zurück zum Zitat Tomizawa J, Itoh T, Selzer G, et al. Inhibition of ColE1 RNA primer formation by a plasmid-specified small RNA. Proc Natl Acad Sci USA. 1981;78:1421–5.PubMedCentralPubMedCrossRef Tomizawa J, Itoh T, Selzer G, et al. Inhibition of ColE1 RNA primer formation by a plasmid-specified small RNA. Proc Natl Acad Sci USA. 1981;78:1421–5.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Simons RW, Kleckner N. Biological regulation by antisense RNA in prokaryotes. Annua Rev Genet. 1988;22:567–600.PubMedCrossRef Simons RW, Kleckner N. Biological regulation by antisense RNA in prokaryotes. Annua Rev Genet. 1988;22:567–600.PubMedCrossRef
14.
Zurück zum Zitat Sun W, Wu Y, Yu X, et al. Decreased expression of long noncoding RNA AC096655. 1-002 in gastric cancer and its clinical significance. Tumor Biol. 2013;34:2697–701.CrossRef Sun W, Wu Y, Yu X, et al. Decreased expression of long noncoding RNA AC096655. 1-002 in gastric cancer and its clinical significance. Tumor Biol. 2013;34:2697–701.CrossRef
16.
Zurück zum Zitat Pang Q, Ge J, Shao Y, et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumor Biol. 2014. doi:10.1007/s13277-014-1709-3. Pang Q, Ge J, Shao Y, et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumor Biol. 2014. doi:10.​1007/​s13277-014-1709-3.
18.
Zurück zum Zitat Wahlestedt C. Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov Today. 2006;11:503–8.PubMedCrossRef Wahlestedt C. Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov Today. 2006;11:503–8.PubMedCrossRef
Metadaten
Titel
Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance
verfasst von
Xinxiu Lin
Man Yang
Tian Xia
Junming Guo
Publikationsdatum
01.07.2014
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 7/2014
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0042-4

Weitere Artikel der Ausgabe 7/2014

Medical Oncology 7/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.